• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[四氢吡喃阿霉素(THP)单次给药对淋巴系统恶性肿瘤的影响]

[Effects of single administration of tetrahydropyranyladriamycin (THP) in lymphoid malignancy].

作者信息

Takagi T, Oguro M, Iwabuchi K

出版信息

Gan To Kagaku Ryoho. 1984 Jul;11(7):1450-6.

PMID:6588924
Abstract

Of 3 patients with adult ALL and 23 patients with NHL treated with intravenous administration of 10 mg/M2 of THP for 5 consecutive days, complete remission was observed in 3 patients and partial remission in 14. The antitumor spectrum of THP seemed to be similar to that of Adriamycin from evidence that THP was effective in patients with NHL of diffuse large and mixed cell type. Neither cardiotoxicity nor alopecia was noticed. Anorexia, nausea or vomiting was mild but granulocytopenia and thrombocytopenia were severe in the patients with ALL and leukemic type NHL. Further studies are required for determining cross resistance to other anthracyclines and an optimal dose schedule.

摘要

对3例成人急性淋巴细胞白血病(ALL)患者和23例非霍奇金淋巴瘤(NHL)患者连续5天静脉注射10mg/M²的吡柔比星进行治疗,3例患者完全缓解,14例部分缓解。从吡柔比星对弥漫大细胞型和混合细胞型NHL患者有效的证据来看,其抗肿瘤谱似乎与阿霉素相似。未观察到心脏毒性和脱发。厌食、恶心或呕吐较轻,但ALL患者和白血病型NHL患者的粒细胞减少和血小板减少严重。需要进一步研究以确定对其他蒽环类药物的交叉耐药性和最佳剂量方案。

相似文献

1
[Effects of single administration of tetrahydropyranyladriamycin (THP) in lymphoid malignancy].[四氢吡喃阿霉素(THP)单次给药对淋巴系统恶性肿瘤的影响]
Gan To Kagaku Ryoho. 1984 Jul;11(7):1450-6.
2
[A phase II study of (2''R)-4'-0-tetrahydropyranyladriamycin (THP) in patients with hematological malignancies. THP Study Group].(2''R)-4'-0-四氢吡喃阿霉素(THP)用于血液系统恶性肿瘤患者的II期研究。THP研究组
Gan To Kagaku Ryoho. 1986 Feb;13(2):368-75.
3
[Phase I trial of 4'-O-tetrahydropyranyl-doxorubicin (THP)--a multi-institutional cooperative study].4'-O-四氢吡喃基阿霉素(THP)的I期试验——一项多机构合作研究
Gan To Kagaku Ryoho. 1985 Jan;12(1):118-24.
4
[Phase II study of (2''R)-4'-O-tetrahydropyranyladriamycin (THP) in patients with solid tumors. Multi-Institutional Cooperative Study].
Gan To Kagaku Ryoho. 1986 Apr;13(4 Pt 1):1060-9.
5
A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.一项关于依达曲沙联合长春碱、阿霉素、顺铂和非格司亭(EVAC/G-CSF)用于晚期恶性肿瘤患者的剂量探索性试验:对非小细胞肺癌具有有前景的抗肿瘤活性。
Cancer J Sci Am. 1997 Sep-Oct;3(5):297-302.
6
[Phase II study of THP (2''R)-4'-0-tetrahydropyranyladriamycin) in breast cancer].THP(2''R)-4'-O-四氢吡喃阿霉素)治疗乳腺癌的II期研究
Gan To Kagaku Ryoho. 1986 Mar;13(3 Pt 1):578-85.
7
[Phase II study of 4'-O-tetrahydropyranyladriamycin(THP-ADM)].4'-O-四氢吡喃阿霉素(THP-ADM)的II期研究
Gan To Kagaku Ryoho. 1984 Jan;11(1):138-42.
8
[A phase II study of epirubicin in malignant lymphoma].
Gan To Kagaku Ryoho. 1986 Aug;13(8):2606-11.
9
[Phase II study of (2''R)-4'-0-tetrahydropyranyladriamycin (THP) in gastrointestinal cancer].(2''R)-4'-0-四氢吡喃阿霉素(THP)治疗胃肠道癌的II期研究
Gan To Kagaku Ryoho. 1985 Nov;12(11):2155-60.
10
(2"-R)-4'-o-tetrahydropyranyladriamycin, a new anthracycline derivative; its effectiveness in lymphoid malignancies.(2“-R)-4'-O-四氢吡喃基阿霉素,一种新的蒽环类衍生物;其在淋巴系统恶性肿瘤中的有效性。
Cancer Chemother Pharmacol. 1987;20(2):151-4. doi: 10.1007/BF00253970.

引用本文的文献

1
A phase II study of (2"R)-4'-0-tetrahydropyranyladriamycin (THP) in hematological malignancies.(2“R)-4'-O-四氢吡喃阿霉素(THP)治疗血液系统恶性肿瘤的II期研究。
Invest New Drugs. 1987;5(3):299-305. doi: 10.1007/BF00175302.
2
(2"-R)-4'-o-tetrahydropyranyladriamycin, a new anthracycline derivative; its effectiveness in lymphoid malignancies.(2“-R)-4'-O-四氢吡喃基阿霉素,一种新的蒽环类衍生物;其在淋巴系统恶性肿瘤中的有效性。
Cancer Chemother Pharmacol. 1987;20(2):151-4. doi: 10.1007/BF00253970.